Mechanisms of delayed anti-tuberculosis protection in the lung of parenteral BCG-vaccinated hosts: A critical role of airway luminal T cells

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Mucosal Immunology

• Publication date

  2012-03-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/mi.2012.19PMID 22453678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• MUCOSAL IMMUNITY AND VACCINES

  2013cited by this paper
• New vaccines for tuberculosis.

  2010cited by this paper
• A key role for lung‐resident memory lymphocytes in protective immune responses after BCG vaccination

  2010cited by this paper
• Airway luminal T cells: a newcomer on the stage of TB vaccination strategies.

  2010cited by this paper
• Murine airway luminal antituberculosis memory CD8 T cells by mucosal immunization are maintained via antigen-driven in situ proliferation, independent of peripheral T cell recruitment.

  2010cited by this paper
• What Role Does the Route of Immunization Play in the Generation of Protective Immunity against Mucosal Pathogens?

  2009cited by this paper
• TB vaccines: current status and future perspectives

  2009cited by this paper
• Accelerated induction of mycobacterial antigen‐specific CD8+ T cells in the Mycobacterium tuberculosis‐infected lung by subcutaneous vaccination with Mycobacterium bovis bacille Calmette–Guérin

  2009cited by this paper
• T cells in mycobacterial infection and disease.

  2009cited by this paper
• DNA vaccines against mycobacterial diseases

  2009cited by this paper
• Immunization of Mice with a Recombinant Adenovirus Vaccine Inhibits the Early Growth of Mycobacterium tuberculosis After Infection

  2009cited by this paper
• Cell-mediated immune responses in tuberculosis.

  2009cited by this paper
• Lessons for tuberculosis vaccines from respiratory virus infection

  2008cited by this paper
• Initiation of the adaptive immune response to Mycobacterium tuberculosis depends on antigen production in the local lymph node, not the lungs

  2008cited by this paper
• Infectious diseases: Too little, too late for tuberculosis

  2008cited by this paper
• IL-23 and IL-17 in the establishment of protective pulmonary CD4+ T cell responses after vaccination and during Mycobacterium tuberculosis challenge

  2007cited by this paper
• A Reduced Antigen Load In Vivo, Rather Than Weak Inflammation, Causes a Substantial Delay in CD8+ T Cell Priming against Mycobacterium bovis (Bacillus Calmette-Guérin)1

  2007cited by this paper
• Heterologous boost vaccines for bacillus Calmette–Guérin prime immunization against tuberculosis

  2007cited by this paper
• Mucosal Luminal Manipulation of T Cell Geography Switches on Protective Efficacy by Otherwise Ineffective Parenteral Genetic Immunization1

  2007cited by this paper
• DNA vaccines against mycobacterial diseases.

  2006cited by this paper
• Memory T cell recruitment to the lung airways.

  2006cited by this paper
• Use of recombinant virus-vectored tuberculosis vaccines for respiratory mucosal immunization.

  2006cited by this paper
• Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness.

  2006cited by this paper
• Mucosal Administration of Ag85B-ESAT-6 Protects against Infection with Mycobacterium tuberculosis and Boosts Prior Bacillus Calmette-Guérin Immunity1

  2006cited by this paper
• Tuberculosis vaccines: current status and future prospects

  2006cited by this paper
• Properties and protective value of the secondary versus primary T helper type 1 response to airborne Mycobacterium tuberculosis infection in mice

  2005cited by this paper
• Mucosal immunity and vaccines

  2005cited by this paper
• Mechanisms of Mucosal and Parenteral Tuberculosis Vaccinations: Adenoviral-Based Mucosal Immunization Preferentially Elicits Sustained Accumulation of Immune Protective CD4 and CD8 T Cells within the Airway Lumen1

  2005cited by this paper
• Single Intranasal Mucosal Mycobacterium bovis BCG Vaccination Confers Improved Protection Compared to Subcutaneous Vaccination against Pulmonary Tuberculosis

  2004cited by this paper
• Activation of CD8 T Cells by Mycobacterial Vaccination Protects against Pulmonary Tuberculosis in the Absence of CD4 T Cells1

  2004cited by this paper
• Single Mucosal, but Not Parenteral, Immunization with Recombinant Adenoviral-Based Vaccine Provides Potent Protection from Pulmonary Tuberculosis1

  2004cited by this paper
• Recombinant Modified Vaccinia Virus Ankara Administration and Boosting with a Bacille Calmette-Guérin Vaccine Using Mucosal of Mycobacterium tuberculosis Efficacy Against Enhanced Immunogenicity and Protective

  2003cited by this paper
• Enhanced Immunogenicity and Protective Efficacy Against Mycobacterium tuberculosis of Bacille Calmette-Guérin Vaccine Using Mucosal Administration and Boosting with a Recombinant Modified Vaccinia Virus Ankara1

  2003cited by this paper

• Advanced Nanosystems and Emerging Therapies: Innovations in Tuberculosis Treatment and Drug Resistance

  2025cites this paper
• Current advancements in nanoparticles for vaccines and drug delivery for the treatment of tuberculosis.

  2025cites this paper
• A Noninvasive Method to Sample Immune Cells in the Lower Female Genital Tract Using Menstrual Discs

  2024cites this paper
• Dendritic Cell Vaccine Harboring Inactivated Mycobacteria Induces Immune Protection Against Tuberculosis in Murine Models and is Well Tolerated in Humans

  2024cites this paper
• Intranasal Immunization with a Recombinant Adenovirus Encoding Multi-Stage Antigens of Mycobacterium tuberculosis Preferentially Elicited CD8+ T Cell Immunity and Conferred a Superior Protection in the Lungs of Mice than Bacillus Calmette–Guerin

  2024cites this paper
• Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity

  2023cites this paper
• Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice

  2023cites this paper
• An overview of the BCG vaccine and its future scope.

  2023cites this paper
• Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung

  2022cites this paper
• Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis

  2022cites this paper
• Boosting BCG with recombinant influenza A virus tuberculosis vaccines increases pulmonary T cell responses but not protection against Mycobacterium tuberculosis infection

  2021cites this paper
• Potential of Curcumin Nanoparticles in Tuberculosis Management

  2021cites this paper
• BCG vaccination strategies against tuberculosis: updates and perspectives

  2021cites this paper
• Tuberculosis Vaccines

  2021cites this paper
• Recombinant Bacillus Calmette-Guérin for Mucosal Immunity

  2020cites this paper
• Interleukin-2-Inducible T-Cell Kinase Deficiency Impairs Early Pulmonary Protection Against Mycobacterium tuberculosis Infection

  2020cites this paper
• Innate immune memory of tissue‐resident macrophages and trained innate immunity: Re‐vamping vaccine concept and strategies

  2020cites this paper
• Impact of etonogestrel implant use on T-cell and cytokine profiles in the female genital tract and blood

  2020cites this paper
• Airway Macrophages Mediate Mucosal Vaccine–Induced Trained Innate Immunity against Mycobacterium tuberculosis in Early Stages of Infection

  2020cites this paper
• Bacillus Calmette Guerin

  2020cites this paper
• Innovative Therapeutic and Vaccine Approaches against Respiratory Pathogens

  2020cites this paper
• Airway delivery of both a BCG prime and adenoviral boost drives CD4 and CD8 T cells into the lung tissue parenchyma

  2020cites this paper
• Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting

  2019cites this paper
• A PATTERN OF TUBERCULOSIS INFECTION AN OVERVIEW

  2019cites this paper
• Mycobacterium indicus pranii Induced Memory T-Cells in Lung Airways Are Sentinels for Improved Protection Against M.tb Infection

  2019cites this paper
• Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells

  2019cites this paper
• Characterization of local and circulating bovine γδ T cell responses to respiratory BCG vaccination

  2019cites this paper
• Early clearance versus control: what is the meaning of a negative tuberculin skin test or interferon-gamma release assay following exposure to Mycobacterium tuberculosis?

  2018cites this paper
• CD11b+ Dendritic Cell–Mediated Anti–Mycobacterium tuberculosis Th1 Activation Is Counterregulated by CD103+ Dendritic Cells via IL-10

  2018cites this paper
• Histone deacetylase 6 inhibitor enhances resistance to Mycobacterium tuberculosis infection through innate and adaptive immunity in mice.

  2018cites this paper
• Pulmonary immunization with a recombinant influenza A virus vaccine induces lung-resident CD4+ memory T cells that are associated with protection against tuberculosis

  2018cites this paper
• Enhanced protection conferred by mucosal BCG vaccination associates with presence of antigen-specific lung tissue-resident PD-1+ KLRG1− CD4+ T cells

  2018cites this paper
• Sequential pulmonary immunization with heterologous recombinant influenza A virus tuberculosis vaccines protects against murine M. tuberculosis infection.

  2018cites this paper
• Dual-Isotope SPECT/CT Imaging of the Tuberculosis Subunit Vaccine H56/CAF01: Induction of Strong Systemic and Mucosal IgA and T-Cell Responses in Mice Upon Subcutaneous Prime and Intrapulmonary Boost Immunization

  2018cites this paper
• New Tuberculosis Vaccine Strategies: Taking Aim at Un-Natural Immunity.

  2018cites this paper
• Nanotechnology-Based Approach in Tuberculosis Treatment

  2017cites this paper
• The role of lung tissue-resident memory T cells in protection against tuberculosis

  2017cites this paper
• Investigating the role of the pulmonary innate immune system in anti-tuberculosis immunity

  2017cites this paper
• Exposure to human alveolar lining fluid enhances Mycobacterium bovis BCG vaccine efficacy against Mycobacterium tuberculosis infection in a CD8+ T cell dependent manner

  2017influential citation
• Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis

  2016cites this paper
• Estradiol Enhances CD4+ T-Cell Anti-Viral Immunity by Priming Vaginal DCs to Induce Th17 Responses via an IL-1-Dependent Pathway

  2016cites this paper
• Oral Tolerance to Environmental Mycobacteria Interferes with Intradermal, but Not Pulmonary, Immunization against Tuberculosis

  2016cites this paper
• Progesterone Levels Associate with a Novel Population of CCR5+CD38+ CD4 T Cells Resident in the Genital Mucosa with Lymphoid Trafficking Potential

  2016cites this paper
• Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens

  2016cites this paper
• Directed Intervention and Immunomodulation against Pulmonary Tuberculosis

  2016cites this paper
• Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis

  2016cites this paper
• Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model

  2015cites this paper
• Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments

  2015cites this paper
• Developing aerosol vaccines for Mycobacterium tuberculosis: Workshop proceedings: National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA, April 9, 2014.

  2015cites this paper
• Novel chimpanzee adenovirus-vectored respiratory mucosal tuberculosis vaccine: overcoming local anti-human adenovirus immunity for potent TB protection

  2015cites this paper
• AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates

  2015cites this paper
• Filling the Immunological Gap: Recombinant Viral Vectors for Mucosal Vaccines

  2015cites this paper
• Aerosol Vaccination with AERAS-402 Elicits Robust Cellular Immune Responses in the Lungs of Rhesus Macaques but Fails To Protect against High-Dose Mycobacterium tuberculosis Challenge

  2014cites this paper
• Attrition of T-Cell Functions and Simultaneous Upregulation of Inhibitory Markers Correspond with the Waning of BCG-Induced Protection against Tuberculosis in Mice

  2014cites this paper
• tuberculosis Mycobacterium Protect against High-Dose Lungs of Rhesus Macaques but Fails To Robust Cellular Immune Responses in the Aerosol Vaccination with AERAS-402 Elicits

  2014cites this paper
• Restoration of innate immune activation accelerates Th1‐cell priming and protection following pulmonary mycobacterial infection

  2014cites this paper
• The role of B cells in respiratory mucosal AdHu5Ag85A vaccine-induced immunity against tuberculosis

  2014cites this paper
• The Role of T cells In Mucosal Immunity against Mycobacterium tuberculosis (Mtb) Infection: A Review of Current Understanding

  2014cites this paper
• New approaches to TB vaccination.

  2014cites this paper
• Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.

  2014cites this paper
• RESPIRATORY MUCOSAL IMMUNIZATION AGAINST PULMONARY TB

  2014cites this paper
• Modulation of respiratory mucosal immunity against pulmonary tuberculosis

  2014cites this paper
• Persistent BCG bacilli perpetuate CD4 T effector memory and optimal protection against tuberculosis.

  2014cites this paper
• Harnessing local and systemic immunity for vaccines against tuberculosis

  2013cites this paper
• Pulmonary M. tuberculosis infection delays Th1 immunity via immunoadaptor DAP12-regulated IRAK-M and IL-10 expression in antigen-presenting cells

  2013cites this paper
• Immunization strategies against pulmonary tuberculosis: considerations of T cell geography.

  2013cites this paper
• Continuous and Discontinuous Cigarette Smoke Exposure Differentially Affects Protective Th1 Immunity against Pulmonary Tuberculosis

  2013cites this paper
• Understanding Delayed T-Cell Priming, Lung Recruitment, and Airway Luminal T-Cell Responses in Host Defense against Pulmonary Tuberculosis

  2012cites this paper
• Regulation of TB Vaccine-Induced Airway Luminal T Cells by Respiratory Exposure to Endotoxin

  2012cites this paper